News
Find out more about lupus: the symptoms, types, causes, and who is at risk for developing this chronic autoimmune disease.
FDA starts a review of Roche's Gazyva as a treatment for lupus nephritis, an indication that analysts think could unlock renewed sales growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results